Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain.

ABSTRACT: Background: Although intermittent androgen deprivation therapy was introduced many years ago to improve patients' quality of life with the same carcinologic efficiency as continuous hormonal therapy, recent data suggest that intermittency could be underutilised. This study aims to estimate the prevalence of prostate cancer patients receiving intermittent androgen deprivation therapy in Spain. Methods: A retrospective, longitudinal study was conducted using electronic drug dispensation data from four Spanish autonomous communities, which encompass 17.23 million inhabitants (36.22% of the total population in Spain). We estimated intermittent androgen therapy use (%IAD) and the prevalence of patients under intermittent androgen therapy in reference to the total number of PC pati

SUBMITTER: Bonfill-Cosp X 

PROVIDER: S-EPMC9614286 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature